EMAIL THIS PAGE TO A FRIEND

Journal of cellular biochemistry

Elucidation of the roles of the Src kinases in pancreatic acinar cell signaling.


PMID 25079913

Abstract

Recent studies report the Src-family kinases (SFK's) are important in a number of physiological and pathophysiological responses of pancreatic acinar cells (pancreatitis, growth, apoptosis); however, the role of SFKs in various signaling cascades important in mediating these cell functions is either not investigated or unclear. To address this we investigated the action of SFKs in these signaling cascades in rat pancreatic acini by modulating SFK activity using three methods: adenovirus-induced expression of an inactive dominant-negative CSK (Dn-CSK-Advirus) or wild-type CSK (Wt-CSK-Advirus), which activate or inhibit SFK, respectively, or using the chemical inhibitor, PP2, with its inactive control, PP3. CCK (0.3, 100 nM) and TPA (1 μM) activated SFK and altered the activation of FAK proteins (PYK2, p125(FAK)), adaptor proteins (p130(CAS), paxillin), MAPK (p42/44, JNK, p38), Shc, PKC (PKD, MARCKS), Akt but not GSK3-β. Changes in SFK activity by using the three methods of altering SFK activity affected CCK/TPAs activation of SFK, PYK2, p125(FAK), p130(CAS), Shc, paxillin, Akt but not p42/44, JNK, p38, PKC (PKD, MARCKS) or GSK3-β. With chemical inhibition the active SFK inhibitor, PP2, but not the inactive control analogue, PP3, showed these effects. For all stimulated changes pre-incubation with both adenoviruses showed similar effects to chemical inhibition of SFK activity. In conclusion, using three different approaches to altering Src activity allowed us to define fully for the first time the roles of SFKs in acinar cell signaling. Our results show that in pancreatic acinar cells, SFKs play a much wider role than previously reported in activating a number of important cellular signaling cascades shown to be important in mediating both acinar cell physiological and pathophysiological responses.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

Y0000113
Carbachol, European Pharmacopoeia (EP) Reference Standard
C6H15ClN2O2
ARK2164
Fumaric acid, PharmaGrade, USP/NF, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production.
C4H4O4
F8509
Fumaric acid, BioReagent, suitable for cell culture
C4H4O4
47910
Fumaric acid, ≥99.0% (T)
C4H4O4
03761
Fumaric acid, tested according to USP/NF
C4H4O4
F0600000
Fumaric acid, European Pharmacopoeia (EP) Reference Standard
C4H4O4
76635
Fumaric acid, certified reference material, TraceCERT®
C4H4O4
F19353
Fumaric acid, 99%
C4H4O4
W248800
Fumaric acid, ≥99%, FCC, FG
C4H4O4
PHR1270
Fumaric Acid, Pharmaceutical Secondary Standard; Certified Reference Material
C4H4O4
G5667
L-Glutamic acid, PharmaGrade, Ajinomoto, EP, manufactured under appropriate GMP controls for Pharma or Biopharmaceutical production, suitable for cell culture
C5H9NO4
W328502
L-Glutamic acid, 99%, FCC
C5H9NO4
G8415
L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%
C5H9NO4
95436
L-Glutamic acid, certified reference material, TraceCERT®
C5H9NO4
G1251
L-Glutamic acid, ReagentPlus®, ≥99% (HPLC)
C5H9NO4
09581
L-Glutamic acid, tested according to Ph.Eur.
C5H9NO4
PHR1107
L-Glutamic acid
C5H9NO4
W297003
Pyruvic acid, ≥97%, FG
C3H4O3
W297070
Pyruvic acid, natural, ≥80%
C3H4O3
P76209
Pyruvic acid, 95%
C3H4O3
72644
Pyruvic acid, technical, ≥95.0% (T)
C3H4O3